NovalGen
2 known investors
NovalGen is a clinical-stage biotechnology company developing multi-specific biologic immunotherapies using its AutoRegulation platform technology, which adds self-regulating capabilities to drugs for safer treatment. Its pipeline targets oncology, autoimmune, haematological, and metabolic disorders.
Investors · 2
Frequently asked questions
- What does NovalGen do?
- NovalGen is a clinical-stage biotechnology company developing multi-specific biologic immunotherapies using its AutoRegulation platform technology, which adds self-regulating capabilities to drugs for safer treatment. Its pipeline targets oncology, autoimmune, haematological, and metabolic disorders.
- Who are NovalGen's investors?
- NovalGen's investors include AlbionVC, UCL Technology Fund.